From: Simulating transmission of ESKAPE pathogens plus C. difficile in relevant clinical scenarios
Mixture | Selective Agar | Bacteria |
---|---|---|
1 | MSA and EMB with 16 μg/mL of Ampicillin | Background (See Table 1) |
A. baumannii | ||
E. faecium | ||
K. pneumoniae | ||
2 | MSA with 24 μg/mL Gentamicin EMB with 8 μg/mL of Gentamicin | Background (See Table 1) |
E. aerogenes | ||
S. aureus | ||
3 | MSA and EMB with 8 μg/mL of Gentamicin C. difficile Agar | Background (See Table 1) |
C. difficile endospores | ||
E. cloacae | ||
P. aeruginosa |